Página principal > Resultados de la búsqueda: Brue, Thierry
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
10 p, 988.4 KB Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly / van der Lely, Aart J. (Erasmus University Medical Center) ; Gomez, Roy (Pfizer Medical Affairs) ; Pleil, Andreas (Pfizer Inc) ; Badia, Xavier (University of Barcelona and Omakase Consulting) ; Brue, Thierry (Centre de Référence des Maladies Rares de l'hypophyse HYPO) ; Buchfelder, Michael (Universitatsklinikum Erlangen) ; Burman, Pia (University of Lund) ; Clemmons, David (UNC Hospitals Diabetes and Endocrinology Clinic) ; Ghigo, Ezio (University Hospital Città Salute e Scienza) ; Jorgensen, Jens Otto Lunde (Aarhus University) ; Luger, Anton (Medizinische Universität und Allgemeines Krankenhaus Wien) ; van der Lans-Bussemaker, Joli (Pfizer Medical Affairs) ; Webb, S. M 1952- (Institut d'Investigació Biomèdica Sant Pau) ; Strasburger, Christian J. (Charitė Universitätsmedizin Berlin) ; Universitat Autònoma de Barcelona
Despite availability of multimodal treatment options for acromegaly, achievement of long-term disease control is suboptimal in a significant number of patients. Furthermore, disease control as defined by biochemical normalization may not always show concordance with disease-related symptoms or patient's perceived quality of life. [...]
2017 - 10.1007/s11102-017-0835-5
Pituitary, Vol. 20 Núm. 6 (january 2017) , p. 692-701  
Registro completo - Creative Commons
2.
12 p, 1.3 MB ESE audit on management of adult growth hormone deficiency in clinical practice / Martel-Duguech, Luciana (Institut d'Investigació Biomèdica Sant Pau) ; Jorgensen, Jens Otto Lunde (Department of Clinical Medicine. Department of Endocrinology and Diabetes) ; Korbonits, Marta (Queen Mary University of London) ; Johannsson, Gudmundur (University of Gothenburg) ; Webb, S. M 1952- (Institut d'Investigació Biomèdica Sant Pau) ; Adamidou, Fotini (Hippokration General Hospital of Thessaloniki) ; Mintziori, Gesthimani (Hippokration General Hospital of Thessaloniki) ; Arosio, Maura (University of Milan) ; Giavoli, Claudia (University of Milan) ; Badiu, Corin (National Institute of Endocrinology 'C. Davila') ; Boschetti, Mara (University of Genoa) ; Ferone, Diego (University of Genoa) ; Bitti, Silvia Ricci (University of Genoa) ; Brue, Thierry (Aix-Marseille Université) ; Albarel, Frederique (Aix-Marseille Université) ; Cannavo, Salvatore (University of Messina) ; Carvalho, Davide (Universidade do Porto) ; Salazar, Daniela Alves (Universidade do Porto) ; Christ, Emanuel (University Hospital Basel (Basilea, Suïssa)) ; Debono, Miguel (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Dusek, Tina (University Hospital Center Zagreb) ; García-Centeno, Rogelio (Hospital General Universitario Gregorio Marañón) ; Ghigo, Ezio (University of Turin) ; Gasco, Valentina (University of Turin) ; Góth, Miklós I. (Hungarian Defense Forces) ; Olah, Dóra (Hungarian Defense Forces) ; Kovacs, Laszlo (Hungarian Defense Forces) ; Høybye, Charlotte (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Kocjan, Tomaz (Univerza V Ljubljani) ; Kozamernik, Katarina Mlekuš (Univerza V Ljubljani) ; Kužma, Martin (University Hospital Bratislava) ; Payer, Juraj (University Hospital Bratislava) ; Medić Stojanoska, Milica (University of Novi Sad) ; Novak, Anela (University Hospital Center Split) ; Miličević, Tanja (University Hospital Center Split) ; Pekic, Sandra (University of Belgrade) ; Milijic, Dragana (University of Belgrade) ; Pérez Luis, Jesus (Universidad de La Laguna) ; Picó Alfonso, Antonio M (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Preda, Veronica (Macquarie University) ; Raverot, Gérald (Hôpital Louis Pradel) ; Borson-Chazot, Francoise (Hôpital Louis Pradel) ; Rochira, Vincenzo (Azienda Ospedaliero-Universitaria di Modena. Ospedale Civile di Baggiovara) ; Monzani, Maria Laura (Azienda Ospedaliero-Universitaria di Modena. Ospedale Civile di Baggiovara) ; Sandahl, Kristian (Aarhus University Hospital (Aarhus, Dinamarca)) ; Tsagarakis, Stylianos (Evangelismos General Hospital) ; Mitravela, Vana (Evangelismos General Hospital) ; Zacharieva, Sabina (Medical University - Sofia) ; Zilatiene, Birute (Lithuanian University of Health Sciences) ; Verkauskiene, Rasa (Lithuanian University of Health Sciences) ; Universitat Autònoma de Barcelona
Guidelines recommend adults with pituitary disease in whom GH therapy is contemplated, to be tested for GH deficiency (AGHD); however, clinical practice is not uniform. Aims: (1) To record current practice of AGHD management throughout Europe and benchmark it against guidelines; (2) To evaluate educational status of healthcare professionals about AGHD. [...]
2021 - 10.1530/EJE-20-1180
European journal of endocrinology, Vol. 184 Núm. 2 (2021) , p. 323-334  
Registro completo - Creative Commons
3.
12 p, 755.8 KB A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly / Trainer, Peter J. (Department of Endocrinology) ; Newell-Price, John D. C. (Royal Hallamshire Hospital) ; Ayuk, John (Medicine Endocrinology) ; Aylwin, Simon J. B. (King's College Hospital NHS Foundation Trust) ; Rees, Aled (Neuroscience and Mental Health Research Institute) ; Drake, William (Department of Endocrinology) ; Chanson, Philippe (Inserm 1185) ; Brue, Thierry (APHM) ; Webb, S. M 1952- (Institut d'Investigació Biomèdica Sant Pau) ; Fajardo, Carmen (Servicio de Endocrinología) ; Aller, Javier (Endocrinology Department) ; McCormack, Ann I (Garvan Institute of Medical Research and St Vincent's Hospital) ; Torpy, David J. (Royal Adelaide Hospital) ; Tachas, George (Antisense Therapeutics Limited) ; Atley, Lynne (Antisense Therapeutics Limited) ; Ryder, David (Manchester Academic Health Science Centre (MAHSC) Clinical Trials Unit) ; Bidlingmaier, Martin (Endocrine Laboratory) ; Universitat Autònoma de Barcelona
ATL1103 is a second-generation antisense oligomer targeting the human growth hormone (GH) receptor. This phase 2 randomised, open-label, parallel-group study assessed the potential of ATL1103 as a treatment for acromegaly. [...]
2018 - 10.1530/EJE-18-0138
European journal of endocrinology, Vol. 179 (may 2018) , p. 97-108  
Registro completo - Creative Commons

Vea también: autores con nombres similares
1 Brue, T.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos